LL-37
Human cathelicidin antimicrobial peptide with broad-spectrum antibacterial, antiviral, and antifungal activity. Also promotes wound healing and modulates
Buy more, save more
Total Price
$99
For research & laboratory use only. Not for human consumption.
Half-Life
~15-30 minutes (rapidly cleaved by proteases; localised depot effects longer)
Administration Route
Subcutaneous injection or topical
Natural Antimicrobial
Human cathelicidin that disrupts bacterial and fungal membranes
Broad Spectrum
Active against MRSA, Pseudomonas, Candida, and enveloped viruses
Immune Modulation
Recruits neutrophils and monocytes to infection sites
Effect Profile
Immune Activation
Anti-Viral Defence
Inflammation Control
Immune Ageing
Mechanism of Action
Scientific Research
Cell Mol Life Sci (2010)
J Invest Dermatol (2004)
Antiviral Res (2009)
Product FAQs
Stacks Well With
KPV
C-terminal tripeptide of alpha-MSH with potent anti-inflammatory activity, studied for gut inflammation, inflammatory bowel disease, and skin wound healing via
Thymosin Alpha-1 (Ta1)
FDA-designated immunomodulator (Zadaxin) approved in 35+ countries for hepatitis B, hepatitis C, and cancer immunotherapy. Activates T-cells and dendritic
BPC-157
Body Protection Compound 157 accelerates healing of tendons, ligaments, muscle, and gut tissue through angiogenesis and growth factor upregulation.
Related Products
Thymosin Alpha-1 (Ta1)
FDA-designated immunomodulator (Zadaxin) approved in 35+ countries for hepatitis B, hepatitis C, and cancer immunotherapy. Activates T-cells and dendritic
KPV
C-terminal tripeptide of alpha-MSH with potent anti-inflammatory activity, studied for gut inflammation, inflammatory bowel disease, and skin wound healing via
VIP (Vasoactive Intestinal Peptide)
28-amino acid neuropeptide with potent anti-inflammatory, bronchodilatory, and gut motility effects. Studied for inflammatory bowel disease, pulmonary